Targeting the Carotid Body Function With Big‐K + ‐Channel Blocker ENA ‐001 in Opioid‐Induced Respiratory Depression: A Scoping Review
Pharmacology Research & Perspectives · 2026-08 · 14 (4)
DOI: 10.1002/prp2.70297 ↗Kurz gefasst
Scoping Review in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 13.07.2026. Verfasst von Jimmy J Arevalo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Respiratory Insufficiency, Carotid Body, Analgesics, Opioid, Potassium Channel Blockers. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Depression
Abstract (Originalsprache)
Opioids, most intravenous anesthetics and various illicit substances can cause fatal respiratory depression by depressing central respiratory networks. ENA‐001, a ventilatory modulator targeting the carotid bodies, has emerged as a potential countermeasure without impairing analgesia or hypnosis. We conducted a literature review to evaluate the efficacy and safety of ENA‐001. This scoping review summarizes the current evidence base for ENA‐001 from in vitro, animal experiments, and human volunteer studies. A comprehensive search was conducted across several electronic databases to identify all available literature describing its effects as a respiratory stimulant and as a reversal agent of drug‐induced respiratory depression. We identified eight relevant publications, four describing data in humans and four using animal models (mice, rats, and non‐human primates). ENA‐001 increased ventilation and attenuated respiratory depression induced by morphine and the combination of xylazine and fentanyl. The primary site of action was localized to the carotid bodies, specifically the pore‐forming α‐subunit of the KCa1.1 (BK) channel. In humans, ENA‐001 increased minute ventilation and reduced end‐tidal carbon dioxide under poikilocapnic conditions. In experimental human models of alfentanil‐ and propofol‐induced respiratory depression, ENA‐001 significantly improved isohypercapnic minute ventilation and fully restored the hypoxic ventilatory response, respectively, without impairing sedation or analgesia. Across all studies, the safety profile was favorable, with no serious adverse events reported. In conclusion, ENA‐001 is a first‐in‐class, peripherally acting respiratory stimulant that effectively reverses drug‐induced respiratory depression. These findings support its continued clinical development for opioid‐ and anesthetic‐induced respiratory compromise.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Anesthesiology and Pain Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
- Department of Anesthesiology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
- Outcomes Research Consortium, Houston, Texas, USA.
- MediD Consultancy Group, Amsterdam, the Netherlands.
- Centre for Human Drug Research, Leiden, the Netherlands.
ORCID-Profile: Jimmy J Arevalo, Monique van Velzen, Maarten van Lemmen, Elise Sarton, Albert Dahan, Marieke Niesters, Rutger M van der Schrier
Zitieren
APA
Arevalo, J. J., van Velzen, M., Jansen, S. C., van Lemmen, M., Sarton, E., Dahan, A., Olofsen, E., Cotten, J. F., Niesters, M., & van der Schrier, R. M. (2026). Targeting the Carotid Body Function With Big‐K + ‐Channel Blocker ENA ‐001 in Opioid‐Induced Respiratory Depression: A Scoping Review. Pharmacology Research & Perspectives, 14(4). https://doi.org/10.1002/prp2.70297
Vancouver
Arevalo JJ, van Velzen M, Jansen SC, van Lemmen M, Sarton E, Dahan A, et al. Targeting the Carotid Body Function With Big‐K + ‐Channel Blocker ENA ‐001 in Opioid‐Induced Respiratory Depression: A Scoping Review. Pharmacology Research & Perspectives. 2026;14(4). doi:10.1002/prp2.70297
BibTeX
@article{Arevalo2026,
author = {Arevalo, Jimmy J and van Velzen, Monique and Jansen, Simone C and van Lemmen, Maarten and Sarton, Elise and Dahan, Albert and Olofsen, Erik and Cotten, Joseph F and Niesters, Marieke and van der Schrier, Rutger M},
title = {Targeting the Carotid Body Function With Big‐K + ‐Channel Blocker ENA ‐001 in Opioid‐Induced Respiratory Depression: A Scoping Review},
journal = {Pharmacology Research & Perspectives},
year = {2026},
volume = {14},
number = {4},
doi = {10.1002/prp2.70297}
}
EUVIMED